Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin

Eric K. Rowinsky, Micheal Jiroutek, Philip Bonomi, David Johnson, Sharyn D. Baker

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin'. Together they form a unique fingerprint.

Medicine & Life Sciences